Company profile
PRUNUS Therapeutics company profile
PRUNUS Therapeutics is a preclinical stage immuno-oncology startup. PRUNUS discovers and develops innovative therapeutics for the human and animal healthcare. PRUNUS’ main platform focuses on small molecules' advantages over high-cost biologics and engineered cells for cancer immunotherapy.
Business identity
- Website
- https://www.prunustx.com/
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0+
- Founded
- 2016-03-16
Headquarters
- Headquarters
- Victoria, Virginia, United States
- Country code
- US
- Continent
- North America